Valuation: Samsung Biologics Co.,Ltd.

Capitalization 89,203B 60.9B 52.26B 48.66B 45.28B 84.5B 5,498B 91.09B 559B 220B 2,630B 228B 224B 9,637B P/E ratio 2025 *
58.1x
P/E ratio 2026 * 47.8x
Enterprise value 87.88B 60M 51.48M 47.93M 44.61M 83.24M 5.42B 89.73M 551M 217M 2.59B 225M 220M 9.49B EV / Sales 2025 *
15.4x
EV / Sales 2026 * 13.9x
Free-Float
25.44%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.00%
1 week+92.70%
Current month+92.70%
1 month+92.70%
3 months+92.70%
6 months+92.70%
Current year+92.70%
More quotes
1 week 1,000,000
Extreme 999999.9999
1,948,000
1 month 1,000,000
Extreme 999999.9999
1,948,000
Current year 1,000,000
Extreme 999999.9999
1,948,000
1 year 1,000,000
Extreme 999999.9999
1,948,000
3 years 1,000,000
Extreme 999999.9999
1,948,000
5 years 1,000,000
Extreme 999999.9999
1,948,000
10 years 192,960.76
Extreme 192960.7607
1,948,000
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 2020-12-08
Director of Finance/CFO 58 2025-03-13
Investor Relations Contact 59 2013-12-31
Director TitleAgeSince
Chairman 64 2020-12-08
Director/Board Member 72 2022-03-28
Director/Board Member 67 2020-03-19
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.00%+92.70%+92.70%+92.70% 60.9B
-0.63%-7.16%+9.16%+4.43% 77.37B
+0.23%+3.05%+36.73%+220.76% 57.48B
+1.03%+0.48%-36.57%-38.91% 55.92B
-5.04%-9.42%+18.35%-41.22% 24.84B
+2.44%-4.18%+47.30%+31.08% 20.8B
-0.50%0.00%+166.07%+111.40% 19.9B
-2.20%-0.85%+51.87%+1,224.82% 17.05B
+2.47%+13.07%+17.76%-78.86% 15.86B
-1.53%+4.89%+118.79%+790.29% 15.01B
Average +0.27%+0.09%+52.22%+231.65% 36.51B
Weighted average by Cap. +0.51%-0.81%+38.65%+136.50%
See all sector performances

Financials

2025 *2026 *
Net sales 5,722B 3.91B 3.35B 3.12B 2.9B 5.42B 353B 5.84B 35.88B 14.12B 169B 14.65B 14.35B 618B 6,223B 4.25B 3.65B 3.39B 3.16B 5.89B 384B 6.35B 39.03B 15.35B 183B 15.93B 15.61B 672B
Net income 1,634B 1.12B 957M 891M 829M 1.55B 101B 1.67B 10.25B 4.03B 48.17B 4.18B 4.1B 177B 1,899B 1.3B 1.11B 1.04B 964M 1.8B 117B 1.94B 11.91B 4.69B 55.99B 4.86B 4.76B 205B
Net Debt -1,325B -905M -776M -723M -673M -1.26B -81.67B -1.35B -8.31B -3.27B -39.07B -3.39B -3.32B -143B -2,588B -1.77B -1.52B -1.41B -1.31B -2.45B -159B -2.64B -16.23B -6.38B -76.29B -6.63B -6.49B -280B
More financial data * Estimated data
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
4,770
More about the company
Date Price Change Volume
26-01-15 1,965,000.00 +1.97% 70,485
26-01-14 1,927,000.00 +1.00% 86,681
26-01-13 1,908,000.00 +2.64% 77,125
26-01-12 1,859,000.00 -1.01% 68,736
26-01-09 1,878,000.00 -0.37% 70,385

End-of-day quote Korea S.E., January 13, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
1,927,000.00KRW
Average target price
2,249,248.65KRW
Spread / Average Target
+16.72%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock